Joanna Hack

Wuhan University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Simon J. Crabb

University of Southampton

Izabella Eberhart

University of Southampton

Amy Hancock

University of Melbourne

Caroline Lee

National University of Singapore

David Woolf

Heriot-Watt University

Jacqui Gath

The Patients Association

Sean Ewings

University of Southampton

Crispin T. Hiley

University College London

T. Geldart

Poole Hospital

M. Hatton

Georgia Southern University

Cooperative Institutions

Wuhan University

Zhongnan Hospital of Wuhan University

University of Southampton

Cancer Research UK

University Hospital Southampton NHS Foundation Trust

Southampton General Hospital

Peter MacCallum Cancer Centre

University of Melbourne

University Hospitals of Cleveland

Case Western Reserve University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Thoracic umbrella radiotherapy study in stage IV NSCLC: TOURIST

Lung Cancer (2023)

David Woolf Robin Wickens Joanna Hack Chris Sutton Andrea Corkhill

10.1016/s0169-5002(23)00619-0

Cite

Citations (0)

Renal Cell Cancer

CRC Press eBooks (2020)

Sarah Ellis Joanna Hack

In 1960, on the basis of electron microscopic features, C. Oberling et al. demonstrated a proximal renal tubular origin, and tumors were renamed renal cell adenocarcinoma or renal cell carcinoma (RCC). Macroscopically clear-cell RCCs have a characteristic appearance with solid areas often interspersed with areas of cystic degeneration. A number of hereditary syndromes are associated with the development of kidney cancer, which tends to present at a younger age with multifocal or bilateral disease. A number of risk factors have been implicated in the development of RCC, including increasing age, cigarette smoking, obesity, and hypertension. The chronic use of analgesics appears to be contributory to the development of RCC in addition with acetaminophen, and non-aspirin non-steroidal anti-inflammatory drugs suggested as the causative agents. Historically surgical removal of the involved kidney in patients presenting with metastatic RCC was undertaken for palliation of symptomatic primary tumors.

10.1201/9780429026638-18

Cite

Citations (0)

ctDNA analysis identifies clinically meaningful resistance mutations in EGFR mutated NSCLC on osimertinib: a case report

Lung Cancer (2022)

Joanna Hack M. Bayne

Osimertinib

Acquired resistance

10.1016/s0169-5002(22)00208-2

Cite

Citations (1)

Quality of Life Trajectories in Patients Treated with R-CHOP for Diffuse Large B-Cell Lymphoma As Part of the Remodl-B Trial (ISRCTN 51837425)